A new study presents a customised treatment strategy using antisense oligonucleotides (ASOs) to target EGFR mutations in ...

For patients with previously treated EGFR-mutated NSCLC, a new BLA has been submitted to the FDA seeking the accelerated ...

By Dr. Sushama R. Chaphalkar, PhD. By combining advanced gene editing techniques, scientists identified key mutations that ...

Lung cancer is the top cause of cancer-related deaths globally, more prevalent in men, and ranks third among women. Both ...

Adenocarcinoma is the most common type of lung cancer in people who have never smoked. 8 In this patient cohort, a ...

Two kinase inhibitors have been recommended by the European Medicines Agency for the treatment of non-small cell lung cancer.

In a study led by researchers at the NUS Yong Loo Lin School of Medicine, extracellular vesicles loaded with customizable ...

Dr Anthony Cunliffe discusses a case of lung cancer that was identified in a non-smoking patient with unusual symptoms ...